KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $3.05 $8.45 Friday, 26th Apr 2024 ABEO stock ended at $3.26. This is 2.19% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.62% from a day low at $3.20 to a day high of $3.38.
90 days $3.05 $9.01
52 weeks $2.85 $9.01

Historical Abeona Therapeutics Inc. prices

Date Open High Low Close Volume
Dec 06, 2021 $14.75 $14.83 $13.88 $14.75 30 702
Dec 03, 2021 $15.26 $15.36 $14.00 $14.38 36 963
Dec 02, 2021 $15.75 $16.24 $15.05 $15.21 39 908
Dec 01, 2021 $17.14 $17.50 $15.00 $15.01 45 672
Nov 30, 2021 $16.60 $17.23 $16.15 $17.23 43 461
Nov 29, 2021 $20.50 $20.74 $16.07 $16.13 123 404
Nov 26, 2021 $18.75 $19.00 $17.65 $18.25 28 942
Nov 24, 2021 $18.38 $19.27 $18.25 $18.93 9 328
Nov 23, 2021 $19.25 $20.63 $18.59 $18.65 42 628
Nov 22, 2021 $19.01 $20.00 $18.50 $19.43 34 324
Nov 19, 2021 $19.00 $19.50 $18.25 $18.53 35 554
Nov 18, 2021 $21.50 $21.63 $18.36 $19.18 73 257
Nov 17, 2021 $21.59 $21.75 $20.75 $21.25 25 170
Nov 16, 2021 $22.65 $22.78 $21.49 $21.78 19 014
Nov 15, 2021 $23.00 $23.55 $22.51 $22.77 24 989
Nov 12, 2021 $23.59 $23.94 $22.50 $22.88 19 493
Nov 11, 2021 $23.00 $24.93 $23.00 $23.39 31 838
Nov 10, 2021 $23.26 $25.45 $23.25 $23.44 22 742
Nov 09, 2021 $24.24 $26.50 $23.00 $24.23 64 169
Nov 08, 2021 $22.44 $24.50 $21.98 $24.23 71 840
Nov 05, 2021 $22.60 $22.69 $22.00 $22.44 28 976
Nov 04, 2021 $23.00 $23.01 $22.15 $22.39 21 989
Nov 03, 2021 $22.00 $23.43 $22.00 $22.78 26 868
Nov 02, 2021 $22.97 $23.25 $22.20 $22.75 32 592
Nov 01, 2021 $20.78 $23.25 $20.50 $22.41 45 379
Click to get the best stock tips daily for free!

About Abeona Therapeutics Inc.

Abeona Therapeutics. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT